FMR LLC - CYMABAY THERAPEUTICS INC ownership

CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 194 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.14 and the average weighting 0.4%.

Quarter-by-quarter ownership
FMR LLC ownership history of CYMABAY THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$23,393,015
+18499.5%
1,568,948
+13559.7%
0.00%
Q2 2023$125,772
-35.9%
11,486
-49.0%
0.00%
Q1 2023$196,270
+178.5%
22,508
+100.2%
0.00%
Q4 2022$70,475
+80.7%
11,240
+0.2%
0.00%
Q3 2022$39,000
+18.2%
11,2150.0%0.00%
Q2 2022$33,000
-5.7%
11,215
-0.5%
0.00%
Q1 2022$35,000
+3400.0%
11,275
+4617.6%
0.00%
Q1 2021$1,000239
+23800.0%
0.00%
Q1 2020$01
-97.4%
0.00%
Q4 2019$0
-100.0%
39
-88.5%
0.00%
Q3 2019$2,000339
+769.2%
0.00%
Q2 2019$0
-100.0%
39
-100.0%
0.00%
Q1 2019$1,630,000
-62.2%
122,739
-77.6%
0.00%
-100.0%
Q4 2018$4,310,000
-77.0%
547,528
-67.6%
0.00%
-50.0%
Q3 2018$18,741,000
-42.2%
1,691,425
-30.0%
0.00%
-50.0%
Q2 2018$32,421,000
-55.3%
2,415,837
-56.7%
0.00%
-55.6%
Q1 2018$72,538,000
+238.8%
5,584,117
+139.9%
0.01%
+200.0%
Q4 2017$21,413,000
+14.1%
2,327,5200.0%0.00%
+50.0%
Q3 2017$18,759,0002,327,5200.00%
Other shareholders
CYMABAY THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 1,653,495$10,367,4148.97%
Versant Venture Management, LLC 543,753$3,409,3307.06%
TCG Crossover Management, LLC 5,905,400$37,026,8586.54%
COMMODORE CAPITAL LP 5,738,500$35,9805.42%
Foresite Capital Management IV, LLC 1,787,094$11,205,0794.79%
Saturn V Capital Management LP 1,611,778$5,718,4324.74%
ACUTA CAPITAL PARTNERS, LLC 1,015,000$6,364,0503.92%
Altium Capital Management LP 1,025,000$6,426,7503.27%
Affinity Asset Advisors, LLC 1,143,531$7,169,9392.81%
GREAT POINT PARTNERS LLC 1,550,000$9,718,5001.90%
View complete list of CYMABAY THERAPEUTICS INC shareholders